• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.10% Nasdaq Up0.21%

    Fate Therapeutics, Inc. (FATE)

    -NasdaqGM
    5.90 0.00(0.00%) 10:10AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development4,568  3,865  4,080  3,968  
    Selling General and Administrative2,756  2,078  1,904  2,072  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (7,324) (5,943) (5,984) (6,040)
    Income from Continuing Operations
    Total Other Income/Expenses Net1  1  (432)1  
    Earnings Before Interest And Taxes(7,323)(5,510)(6,416)(6,039)
    Interest Expense558  291  187  28  
    Income Before Tax(7,881)(5,801)(6,603)(6,067)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(7,881)(5,801)(7,035)(6,067)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (7,881) (6,233) (6,603) (6,067)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (7,881) (6,233) (6,603) (6,067)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.